BRL 34915 (cromakalim) enhances voltage-dependent K+ current in cultured rat hippocampal neurons
- 1 September 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 168 (1) , 7-14
- https://doi.org/10.1016/0014-2999(89)90626-2
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- K+ channels openers prevent epilepsy induced by the bee venom peptide MCDEuropean Journal of Pharmacology, 1989
- Cromakalim, nicorandil and pinacidil: Novel drugs which open potassium channels in smooth muscleGeneral Pharmacology: The Vascular System, 1989
- Anti‐vasoconstrictor effects of the K+ channel opener cromakalim on the rabbit aorta—comparison with the calcium antagonist isradipineBritish Journal of Pharmacology, 1988
- Potassium efflux enhancement by cromakalim (BRL 34915) in rabbit mesenteric artery: An indirect effect independent of calcium?Biochemical Pharmacology, 1988
- Similarity of relaxations evoked by BRL 34915, pinacidil and field‐stimulation in rat oesophageal tunica muscularis mucosaeBritish Journal of Pharmacology, 1988
- The potassium channel opener cromakalim (BRL 34915) activates ATP-dependent K+ channels in isolated cardiac myocytesBiochemical and Biophysical Research Communications, 1988
- Phencyclidine at low concentrations selectively blocks the sustained but not the transient voltage-dependent potassium current in cultured hippocampal neuronsNeuroscience Letters, 1988
- Specificity of action of the novel antihypertensive agent, BRL 34915, as a potassium channel activatorBiochemical Pharmacology, 1987
- Electrical and mechanical effects of BRL34915 in guinea‐pig isolated trachealisBritish Journal of Pharmacology, 1986
- Comparison of the effects of BRL 34915 and verapamil on electrical and mechanical activity in rat portal veinBritish Journal of Pharmacology, 1986